Dogs that have oral squamous cell carcinomas often need surgery that disfigures their jaws and lower their quality of ...

Australia: Researchers have found in a small study that immune checkpoint inhibitors (ICIs) used for cancer treatment ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs ...

Ken Kato, MD, PhD, and Harry H. Yoon, MD, MHS, discussed the recent FDA approval of tislelizumab in the first line for patients with esophageal squamous cell carcinoma.

“FDA approval of TEVIMBRA for the first-line treatment of advanced esophageal squamous cell carcinoma marks a significant step forward in tackling the unmet needs in this challenging disease are ...

Dr Toral Vaidya, a New York City based board certified dermatologist, recently shared signs and symptoms of skin cancer she ...

Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs) found that patients responded better to a combination of two ...

SCI Corporation ("CEL-SCI" or the "Company") (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced ...

The table is a review of notable updates that occurred in February 2025 for investigational products in development.

Dogs that have oral squamous cell carcinomas often need surgeries that disfigure their jaws and lower their quality of life - and in 20% of dogs ...

In a clinical practice guideline issued by the American Society for Radiation Oncology and published online Feb. 27 in ...